Comorbidity of Paranoid Schizophrenia and Synthetic Cannabinoid Addiction
Buch in deiner Nähe kaufen
Beschreibung
Based on a large-scale study, this book offers a contemporary perspective on the clinical, dynamic, socio-psychological, and adaptive characteristics of paranoid schizophrenia when it co-occurs with synthetic cannabinoid dependence. It also outlines targeted treatment and rehabilitation programs designed to help patients reintegrate into socially accepted, recovery-focused communities.
The study found that the coexistence of these two disorders leads to significant clinical and dynamic changes in both conditions. These include a polymorphism of clinical symptoms during schizophrenia exacerbations, compounded by the addition of synthetic cannabinoid withdrawal syndrome. By the third year, the schizophrenic process often becomes continuously progressive, accompanied by a slow increase in negative psychopathological symptoms and a notable “distortion” of these symptoms.
For the first time, six clinical variants of synthetic cannabinoid withdrawal syndrome are described. The book demonstrates the dominance of destructive psychological defenses, unfavorable adaptation patterns, and specific types of compensatory adaptive mechanisms.
This book offers a contemporary perspective on the clinical, dynamic, socio-psychological, and adaptive characteristics of paranoid schizophrenia when it co-occurs with synthetic cannabinoid dependence, based on a large-scale study. It also outlines targeted treatment and rehabilitation programs designed to help patients reintegrate into socially accepted, recovery-focused communities.
The study found that the coexistence of these two disorders leads to significant clinical and dynamic changes in both conditions. These include a polymorphism of clinical symptoms during schizophrenia exacerbations, compounded by the addition of synthetic cannabinoid withdrawal syndrome. By the third year, the schizophrenic process often becomes continuously progressive, accompanied by a slow increase in negative psychopathological symptoms and a notable “distortion” of these symptoms.
For the first time, six clinical variants of synthetic cannabinoid withdrawal syndrome are described. The book demonstrates the dominance of destructive psychological defenses, unfavorable adaptation patterns, and specific types of compensatory adaptive mechanisms.
Explores behavior patterns and provides a psychological profile of these patients, highlighting their typical responses Analyzes the impact of different synthetic cannabinoids on the psychopathological processes of schizophrenia Presents modern approaches to pharmacotherapy and rehabilitation for treating these comorbid conditions
Autor*in
Masood Zangeneh
Themen in »Comorbidity of Paranoid Schizophrenia and Synthetic Cannabinoid Addiction«
schizophrenia synthetic cannabinoids drug therapy pathogenesis suicide prevention